GlassScriptPhysician profile
Mark Joseph Twardzik
NPI 1801965090
$755.73
in general payments reported to CMS, 2019-2025
9 companies · $37.31 in 2025
The $37.31 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $65.59 · 2020: $62.51 · 2021: $175 · 2022: $277 · 2023: $66.99 · 2024: $71.60 · 2025: $37.31.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $176.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $175.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $394.36 | 2020-2025 | Grafix Pl, Stravix, Pico 14 |
| Organogenesis INC. | $181.17 | 2022-2024 | Affinity |
| Melinta Therapeutics, LLC | $53.84 | 2019 | |
| Kerecis Limited | $30.42 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Paratek Pharmaceuticals, INC. | $28.69 | 2020 | |
| Misonix INC | $22.52 | 2021 | |
| Abbvie INC. | $16.77 | 2023 | Dalvance |
| Acera Surgical, INC. | $16.21 | 2022 | |
| Medline Industries LP | $11.75 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Twardzik listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.